3SBio (SSRX) Shares Downgraded to Hold by Auriga Analysts - LocalizedUSA PDF Print
LocalizedUSA
The Company's recombinant, or genetically engineered, protein-based products and product candidates are designed to address large markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.